Document is current
Any future updates will be listed below
-
Authors
Xu, Qiang
Zhao, Xue
Wang, Xianze
Zhu, Ruizhe
Cheng, Yuejuan
Xia, Tao
Wu, Heshui
Tian, He
Sun, Yuping
Zhang, Mingjun
Gao, Chuntao
Fu, Deliang
Wu, Xiaojie
Zheng, Tongsen
Yin, Xiaoyu
Chen, Yili
Chen, Xiaobing
Li, Zhihua
Chen, Rufu
Yang, Xue
Wang, Huan
Wang, Quanren
Han, Xiaohong
Wu, Wenming
-
Funding
Funding for this research was provided by:
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- License Information
-
More Information
Article History
Received: 31 May 2024
Accepted: 19 June 2025
First Online: 7 July 2025
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. The protocol and all amendments were approved by the Ethics Committee of Peking Union Medical College Hospital (20211-EA1), Zhejiang Provincial People's Hospital (2021YW126), Union Hospital Tongji Medical College, Huazhong University of Science and Technology (2021–0910), Shandong Cancer Hospital and Institute (SDZLEC2021-136–01), The Second Affiliated Hospital of Anhui Medical University (YW2021-160), Tianjin Medical University Cancer Institute & Hospital (E20210935), Huashan Hospital Fudan University (2021–950), Harbin Medical University Cancer Hospital (2021–224), The First Affiliated Hospital, Sun Yat-sen University (2021–107), The Affiliated Cancer Hospital, Zhengzhou University (2021–357-003), Sun Yat-sen Memorial Hospital, Sun Yat-sen University (2021-YW-099), and Guangdong Provincial People's Hospital (YW2021-101). All patients provided written informed consent.
: Not applicable.
: Xue Yang, Huan Wang, and Quanren Wang reports being employed by Jiangsu Hengrui Pharmaceuticals Co., Ltd. No other disclosures are reported.
